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cGMP is characterized as undetectable in yeast [(1986) Yeast Cell Biology, UCLA Symp. Mol. Cell Biol. (Hicks, J. ed.) 
p.4951, though in many organisms it contributes pecifically to the regulation of metabolism. Here, we detected cGMP, 
using radioactive labeling and RIA techniques, after extraction of the cells with 1 mol/l HClO, at 37°C. The cGMP 
0.015fold CAMP, about 3-times higher with exponentially growing cells than with pressed baker’s yeast, and depends 
on glucose and 0, supply. The PDE inhibitors DMX and IBMX induce in growing cells an additional increase of the 
cGMP level, without similar effects on CAMP. 
cyclic GMP; Yeast; (Succharomyces cerevisine) 
1. INTRODUCTION 
Though most bacteria and animal cells are pro- 
vided with cGMP as well as with CAMP, no infor- 
mation on cGMP in yeast is available; cGMP is 
characterized as ‘undetectable’ in yeast [I]. How- 
ever, in several eucaryotic organisms cGMP per- 
forms special regulatory functions (reviews [2,3]). 
In bacteria, cGMP takes part in processes of 
repression/derepression, in some cases in a direc- 
tion opposite to that occurring in CAMP [4,5]. It 
seemed of interest, therefore, to re-examine the 
equipment of yeast with cGMP. We detected 
cGMP in extracts from Saccharomyces cerevisiae. 
The cGMP level depends on the metabolic state of 
the cells, and is modified when growing yeast is in- 
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cubated with the PDE inhibitors 1,3-dimethyl- 
xanthine, or 3-isobutyl-I-methylxanthine, respec- 
tively. 
2. MATERIALS AND METHODS 
2.1. Yeast strains and growth conditions 
A clone formerly separated from baker’s yeast (‘Germania 
Hefe’, Deutsche Hefewerke, Hamburg, FRG) was used 
throughout all experiments. Commercially available baker’s 
yeast (L’Hirondelle, Lesaffre, Marc en Baroeul, France) was 
used additionally in some experiments. Yeast was grown 
aerobically at 31°C on a modified Wickerham medium [6] with 
vigorous aeration and stirring. In principle the medium was in- 
oculated with an appropriate cell number and the culture grown 
overnight at 31°C. At l-5 x ld cells/ml, the culture was im- 
mediately taken for the experiments. 
2.2. Chemicals 
[2,8-‘H]Adenosine 3 ’ ,5 ‘-cyclic phosphate ([3H]cAMP, 
37 MBq/ml, 1332 GBq/mmol), [&‘H]guanosine 5’-triphos- 
phate ([‘HIGTP, 37 MBq/ml, 396 GBq/mmol), and rabbit 
anti-cGMP antiserum were from Amersham-Buchler (Braun- 
schweig, FRG). [Il-“H(N)]Guanosine 3 ’ ,5 ‘-cyclic phosphate 
([‘H]cGMP, 37 MBq/ml, 636.4 GBq/mmol) was from NEN 
(Dreieich, FRG). Unlabeled cyclic nucleotides, other nucleo- 
tides, PDE (EC 3.1.4.17) from bovine heart and other enzymes 
were from Boehringer (Mannheim, FRG). DMX and Norit A 
were from Serva (Heidelberg, FRG). IBMX was obtained from 
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Sigma (St. Louis, MO, USA). Triethylamine was from Fluka 
(Buchs, Switzerland). Rabbit anti-CAMP antiserum was 
prepared by Dr M. Schumacher and made available by Pro- 
fessor Hilz (Hamburg, FRG). 
2.3. In vivo labeling and detection of cGMP 
Radioactive labeling in vivo, and separation and identifica- 
tion of cGMP are described in detail elsewhere [7]. In brief, ex- 
ponentially growing yeast was incubated for 210 min with 
4.625 kBq (1.168 mmol) [3H]GTP/107 cells per ml, then ex- 
tracted with 1 mol/l HCl04, and the nucleotides eparated by 
adsorption to Norit A. After elution, the nucleotides were 
chromatographed on silica gel thin-layer plates with an 
isopropanol/water/ammonia mixture (7 : 2 : l), usinig 25 nmol 
each of cCMP and CAMP as tracer, and adenosine, guanosine, 
and their respective mono- and triphosphates as control 
markers. The UV-absorbing spots were moistened with water, 
scraped off, and counted in a liquid scintillation spectrometer. 
2.4. Phosphodiesterase assay 
The standard assay contained in a final volume of 85 ,ul, 
0.82 mmol/l MgCl2, 0.21 mmol/l NazEDTA, 20’.5 mmol/l 
Tris, 50 pl Norit eluate, and 0.1 mg PDE (0.25 U/mg), pH 7.5. 
Control assays contained (i) an additional 5 nmol (370 Bq) 
[‘H]cGMP, (ii) 0.5 pmol (370 Bq) or 5 nmol (370 Bq) 
[‘H]cGMP instead of the Norit eluate, (iii) no enzyme. The 
assays were incubated for 60 min at 37’C, then 5 min at 95”C, 
centrifuged, and the clear supernatant was analyzed by thin- 
layer chromatography. About 65% of labeled cGMP was 
degraded when the standard assay was supplemented with 
[‘H]cGMP. In contrast, more than 90% of the labeled cGMP 
was recovered after incubation without PDE. 
2.5. Estimation of cGMP by RIA 
Cyclic nucleotides were estimated from yeast extracts by the 
RIA technique according to Steiner et al. [8] with some 
modifications as described in detail [7]. cGMP was estimated in 
the acetylated form. Yeast extracts were prepared from 1 x 
10*-l x lo9 cells by incubation with 2.0 ml HCl04, 1 mol/l, 
for 60 min at 37°C and 5 min in an ice bath. After centrifuga- 
tion, the supernatant was adjusted to pH 7.0-7.2 with 5 mol/l 
KOH and 1 mol/l potassium phosphate buffer (pH 7.4). The 
precipitate was centrifuged off. The clear supernatant was 
taken for the RIA. The yield of cyclic nucleotides increased in 
proportion to the number of cells extracted, up to lo9 cells. 
Recovery of cyclic nucleotides added to the yeast together with 
HCl04 was more than 95%. No cross-reactions between the an- 
tisera and the ‘false’ cyclic nucleotides were observed (details 
[71h 
3. RESULTS 
3.1. Detection of cGA4P in yeast: in vivo labeling 
When an exponentially growing yeast culture 
(10 x lo6 cells/ml) is supplemented with [3H]GTP, 
and growth is continued for 210 min, about 5% of 
the incorporated, radioactivity is found in the acid- 
soluble cell fraction. Separation of this material by 
TLC exhibits radioactivity comigrating with 
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cGMP, and with CAMP, respectively, showing 
more label associated with cGMP than with 
CAMP. Incubation of the labeled acid-soluble 
material with PDE results in a marked loss of 
radioactivity from both the cGMP and the CAMP 
fractions (table 1). 
3.2. Detection of cGMP by RIA technique 
cGMP can also be detected in the acid-soluble 
cell fraction by the RIA technique. Extensive pilot 
tests (not shown here) revealed, however, that ex- 
traction of the cells by 1 mol/l HC104 at 37°C is 
an essential requirement for success. Any interac- 
tion of the anti-cGMP antiserum with CAMP can 
be excluded. 
3.3. Influence of glucose repression and 0~ 
About three times as much cGMP as with 
pressed baker’s yeast is found with cells from an 
exponentially growing culture (table 2). When ex- 
ponentially grown yeast is incubated under aerobic 
conditions, but only with glucose and potassium 
phosphate as substrates, cGMP decreases to 45%, 
and on additional 02-starvation to about 37%. 
Similar changes occur with CAMP. The ratio 
cGMP : CAMP thus remains nearly constant. 
3.4. Effect of PDE inhibitors 
When exponentially growing yeast is exposed to 
DMX (5 x 10e3 mol/l), the level of cGMP tem- 
porarily is increased significantly above the control 
after a lag of more than 40 min (fig.lA). Neither 
the level of CAMP, nor the DNA and protein con- 
tents of the cells are affected essentially, even after 
continued cell growth (not shown here). 
With IBMX (1 x 10m3 mol/l), the level of cGMP 
Table 1 
Detection of cyclic nucleotides from yeast extracts by TLC 
Rr dpm/lO’ cells 
I II 
cGMP 0.30 18650 7180 
CAMP 0.44 13600 5170 
Exponentially growing yeast was incubated with [3H]GTP, 
extracted with HCl04, and the labeled nucleotides were 
separated by TLC. cGMP and CAMP were detected by UV- 
absorption, and identified by the Rr-values. I, control after 
incubation in a PDE assay, but without enzyme; II, after 
incubation with PDE. Mean from three experiments 
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Table 2 
cGMP and CAMP in extracts from yeast kept in different 
metabolic states 
pmol/lOg cells cGMP/ 
CAMP 
cGMP CAMP 
(a) Pressed baker’s yeast 5.9 f 2.8 346 f 109 0.017 
(b) Exponentially 
growing yeast 
(c) With glucose + 
20.6 f 6.2 1713 f 286 0.012 
phosphate, aerated 9.3 f 1.4 654 f 120 0.014 
(d) With glucose + 
phosphate, but 
starved of 02 7.6 f 2.5 580 f 134 0.013 
(a) Commercially available baker’s yeast (‘Germania Hefe’, 
DHW, Hamburg), washed twice with water, and resuspended 
with water. (b) Yeast grown exponentially overnight up to 1 x 
lo6 cells/ml (c) Yeast from an exponentially growing culture, 
washed twice with water, and reincubated (1 x lo6 cells/ml) 
overnight with 0.44 mol/l glucose in 0.05 mol/l potassium 
phosphate buffer, pH 6.5, at vigorous aeration and stirring. (d) 
Yeast treated as in c, but without stirring and aeration. Means 
from two experiments, four analyses per experiment 
in growing yeast likewise is raised above the con- 
trol (fig.lB). The lag is less than 20 min. When 
IBMX is removed by washing and reincubating the 
cells with fresh cold growth medium, the cGMP 
level is already normalized at zero time of rein- 
cubation. Again, no effects upon the levels of 
CAMP, DNA and protein are observed. 
4. DISCUSSION 
Our labeling experiments, and the studies by the 
RIA technique, show that the yeast S. cerevisiae 
like most other organisms is equipped not only 
with CAMP, but also with cGMP. In contrast to 
CAMP, cGMP becomes detectable, however, only 
after a relatively strong treatment of the cells with 
1 mol/l HC104 at 37°C. Maximum values are ob- 
tained after a 60 min extraction. These conditions 
differ considerably from the standard extraction 
procedure for low-molecular-mass yeast cell con- 
stituents, e.g. NAD or nucleoside triphosphates, 
namely 10% trichloroacetic acid for 10 min at 
room temperature. The reason for this difference 
is not clear. However, this might explain, in part, 
why cGMP so far seemed to be ‘undetectable’ [l]. 
The intracellular level of cGMP depends on the 
metabolic conditions. The differences between 
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Fig.1. cGMP level in yeast growing with xanthine derivatives. 
Aliquots from exponentially growing cultures (about 5 x lo6 
cells/ml) were supplemented with 5 x lo-’ mol/l DMX (A), 
and with 1 x 10e3 mol/l IBMX (B), respectively, and the 
incubation continued. At the indicated times, 1 x 10s cells were 
harvested from aliquots, extracted, and cGMP was estimated. 
Values are means + SD. According to Student’s t-test, control 
and DMX values differ significantly (P < 0.05) at 60 and 
80 min. With IBMX, the differences are significant (P < 0.05) 
at 20, 80 and 120 min. ( -) Control; (A---A) DMX; 
(m) IBMX. 
pressed baker’s yeast, yeast fermenting glucose 
aerobically or anaerobically, and cells growing ex- 
ponentially, indicate that not only glucose acts as 
a positive effector on the cGMP level. In this 
regard, the situation resembles that described for 
Escherichia coli and Bacillus licheniformis [9]. But 
in contrast to E. coli [9,10], cGMP behaves like 
CAMP, the molar ratios between both cyclic 
nucleotides being nearly the same at all metabolic 
states. CAMP increases in yeast under conditions 
of derepression [11,121, thus modifying metabolic 
pathways by stimulation of protein kinase [ 13- 161. 
Our findings suggest that cGMP might play a 
similar role. Evidence obtained recently on a 
cGMP dependent protein kinase from yeast [17] 
supports this view. 
When yeast is grown in the respective presence 
of DMX or IBMX, the cGMP level increases 
significantly above the control. This is not the case 
with CAMP, though we cannot exclude a quick 
short-lived reaction, as observed [12] at derepres- 
sion by trehalose. It remains unknown whether dif- 
ferent sensitivities to DMX and IBMX of cGMP- 
and CAMP-dependent yeast PDEs are responsible 
for these findings. 
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